As of Jan 18
| +0.97 / +1.19%|
The 21 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 100.00, with a high estimate of 145.00 and a low estimate of 75.00. The median estimate represents a +21.18% increase from the last price of 82.52.
The current consensus among 27 polled investment analysts is to Hold stock in Vertex Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.